MCT INHIBITION SYNERGIZES WITH TYROSINE KINASE AND MTOR INHIBITOR TREATMENT IN RENAL CELL CARCINOMA

被引：0
|
作者：
Jambunathan, Bhaghyasree
Dergham, Abdo
Bhattacharjee, Sayani
Wynn, Rebecca
Sindhwani, Puneet
Petros, Firas
Nadiminty, Nagalakshmi
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD43-03
引用
收藏
页码：E702 / E702
页数：1
相关论文
共 50 条
  • [1] TYROSINE KINASE AND MTOR INHIBITION IN RENAL CELL CARCINOMA SPHEROIDS
    Kraemer, Kai
    Mattissek, Claudia
    Wuttig, Daniela
    Herrmann, Jana
    Fuessel, Susanne
    Grimm, Marc-Oliver
    Wirth, Manfred P.
    JOURNAL OF UROLOGY, 2010, 183 (04): : E33 - E33
  • [2] Combining Checkpoint and Tyrosine Kinase Inhibitor in the Treatment of Renal Cell Carcinoma
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (05) : 247 - 247
  • [3] Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors
    Weikert, Steffen
    Kempkensteffen, Carsten
    Busch, Jonas
    Johannsen, Manfred
    Gruenwald, Viktor
    Zimmermann, Kaja
    Floercken, Anne
    Westermann, Joerg
    Weinkauf, Lisa
    Miller, Kurt
    Keilholz, Ulrich
    WORLD JOURNAL OF UROLOGY, 2013, 31 (04) : 805 - 809
  • [4] Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitors
    Steffen Weikert
    Carsten Kempkensteffen
    Jonas Busch
    Manfred Johannsen
    Viktor Grünwald
    Kaja Zimmermann
    Anne Flörcken
    Jörg Westermann
    Lisa Weinkauf
    Kurt Miller
    Ulrich Keilholz
    World Journal of Urology, 2013, 31 : 805 - 809
  • [5] Pazopanib The Newest Tyrosine Kinase Inhibitor for the Treatment of Advanced or Metastatic Renal Cell Carcinoma
    Keisner, Sidney V.
    Shah, Sachin R.
    DRUGS, 2011, 71 (04) : 443 - 454
  • [6] Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3
    Penel, Nicolas
    BULLETIN DU CANCER, 2017, 104 (09) : 705 - 706
  • [7] Pazopanib: The newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma
    Keisner S.V.
    Shah S.R.
    Drugs, 2011, 71 (4) : 443 - 454
  • [8] Inhibition of' renal cell carcinoma growth in bone by the receptor tyrosine kinase inhibitor, PKI166.
    Weber, K
    Doucet, M
    Price, J
    Fidler, IJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S228 - S228
  • [9] Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor
    Hailiang Zhang
    Lin Bai
    Xin-Qiang Wu
    Xi Tian
    Jinwen Feng
    Xiaohui Wu
    Guo-Hai Shi
    Xiaoru Pei
    Jiacheng Lyu
    Guojian Yang
    Yang Liu
    Wenhao Xu
    Aihetaimujiang Anwaier
    Yu Zhu
    Da-Long Cao
    Fujiang Xu
    Yue Wang
    Hua-Lei Gan
    Meng-Hong Sun
    Jian-Yuan Zhao
    Yuanyuan Qu
    Dingwei Ye
    Chen Ding
    Nature Communications, 14
  • [10] Proteogenomics of clear cell renal cell carcinoma response to tyrosine kinase inhibitor
    Zhang, Hailiang
    Bai, Lin
    Wu, Xin-Qiang
    Tian, Xi
    Feng, Jinwen
    Wu, Xiaohui
    Shi, Guo-Hai
    Pei, Xiaoru
    Lyu, Jiacheng
    Yang, Guojian
    Liu, Yang
    Xu, Wenhao
    Anwaier, Aihetaimujiang
    Zhu, Yu
    Cao, Da-Long
    Xu, Fujiang
    Wang, Yue
    Gan, Hua-Lei
    Sun, Meng-Hong
    Zhao, Jian-Yuan
    Qu, Yuanyuan
    Ye, Dingwei
    Ding, Chen
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345